Concepedia

Ester Blanco

EB

Statistics

Publications

8

Citations

163

H-Index

8

Active since

2022

Affiliations

Navarre Institute of Health Research(Current)

Navarrabiomed

Universidad de Navarra

Universidad Pública de Navarra (UPNA)

Clinica Universidad de Navarra

Ester Blanco is an author at Navarre Institute of Health Research specializing in oncology, immune checkpoint inhibitors, and cancer immunotherapy.

ORCID

Publications per year

2022–2024

8

Publications

8

Circulating Low Density Neutrophils Are Associated with Resistance to First Line Anti-PD1/PDL1 Immunotherapy in Non-Small Cell Lung Cancer

Hugo Arasanz, Ana Bocanegra, Idoia Morilla et al. · Cancers · 2022 · 39 citations · Full text

, , +17

LAMC2 Regulates Key Transcriptional and Targetable Effectors to Support Pancreatic Cancer Growth

Oihane Erice, Shruthi Narayanan, Iker Feliu et al. · Clinical Cancer Research · 2023 · 34 citations

, , +17

Local delivery of optimized nanobodies targeting the PD-1/PD-L1 axis with a self-amplifying RNA viral vector induces potent antitumor responses

Noelia Silva-Pilipich, Ester Blanco, Teresa Lozano et al. · Cancer Letters · 2023 · 18 citations · Full text

, , +17

PD-1/LAG-3 co-signaling profiling uncovers CBL ubiquitin ligases as key immunotherapy targets

Luisa Chocarro, Ester Blanco, Leticia Fernández et al. · EMBO Molecular Medicine · 2024 · 17 citations · Full text

, , +17

Circulating Low Density Neutrophils Are Associated with Resistance to First-Line Anti-PD1/PDL1 Immunotherapy in Non-Small Cell Lung Cancer

Hugo Arasanz, Ana Bocanegra, Idoia Morilla et al. · medRxiv · 2022 · 16 citations · Full text

, , +17

1–5 of 8